Boston Scientific Wins FTC Clearance For £3.3B BTG Deal
The Federal Trade Commission cleared Boston Scientific Corp.'s planned £3.3 billion ($4.2 billion) purchase of U.K.-based BTG PLC Wednesday after the company agreed to sell a cancer-treatment product line and other...To view the full article, register now.
Already a subscriber? Click here to view full article